Monday, April 13, 2020

Systemic Therapy for Metastatic Renal-Cell Carcinoma

Kidney cancers have been extensively studied, and insights from an increased understanding of tumor biology have led to increases in survival rates. Therapies aimed at tumor signaling pathways and immunotherapies have improved the outlook for patients with renal cancer.

No comments:

Post a Comment